Official Title
Evaluation of Immunogenicity of COVID-19 Vaccine in Chinese Population
Brief Summary

The purpose of this study is to evaluate the immunogenicity and immune protection ofCOVID-19, especially the recently prevalent strains, against the background of currentimmunization in Chinese population

Detailed Description

Not Provided

Completed
COVID

Other: No Interventions

No intervention

Eligibility Criteria

Inclusion Criteria:

1. He was infected with COVID-19 from November to December 2022;

2. Have not been infected with COVID-19 (the subject said that he was not infected and
signed the informed consent form);

3. Those who agree and sign the informed consent form.

Exclusion Criteria:

1. Missing or incomplete questionnaires that affect research results;

2. Individuals with combined dysfunction of important organs such as the heart, liver,
and lungs;

3. Mental and behavioral abnormalities;

4. Intellectual disability;

5. Under 18 years old or over 75 years old;

6. Low understanding and communication skills.

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: 75 Years
Countries
China
Locations

The First Affiliated Hospital of Air Force Military Medical University
Xi'an 1790630, Shaanxi 1796480, China

Not Provided

Xijing Hospital
NCT Number